We aimed to determine characteristics of host, causative organisms, and antibiotic susceptibility of bacteria in pediatric patients with UTI living in metropolitan area of Korea. Methods: Retrospective investigation was done for the causative organisms of UTI in 683 pediatric cases treated at Ajou University Hospital from 2012 to 2017. Patients were classified into Escherichia coli and non-E. coli group, where E. coli group was subdivided into ESBL(+) and ESBL(-) groups based on whether the bacteria could produce extended spectrum beta-lactamase (ESBL). Antibiotic susceptibility of the causative organism was also determined. Results: A total of 683 UTIs occurred in 550 patients, of which 463 (67.8%) were first-time infection and 87 (32.2%) were recurrent ones (2-7 recurrences, 2.52 average), and 64.9% were male and 35.1% were female. The most common causative organism was E. coli (77.2%) and ESBL(+) E. coli was found in 126 cases. The susceptibility of E. coli to 3rd or 4th generation cephalosporin was relatively higher than that to ampicillin or amoxicillin/clavulanic acid. ESBL(+) E. coli showed higher resistance rate to 3rd or 4th generation cephalosporin than ESBL(-) E. coli. Conclusion: New treatment guideline should be considered due to the incidence of ESBL(+) E. coli increased up to one quarter of UTI cases.
Introduction
Urinary tract infection (UTI) is one of the most common bacterial infec tions in children. It is the most common cause of fever without focus in infants younger than two years of age. It accounts for 5-14% of pediatric emergency room visits 1, 2) . The prognosis of UTI is good in general. However, over 60% of children with febrile UTI might experience ongoing renal damages resulting in early hypertension, renal insufficiency, or end stage renal failure in adult hood 3, 4) . To prevent renal loss from UTI, it is essential to know the pathophy siology of the disease, including host factors, bacterial factors, and antibiotic resistance 5, 6) . The objective of this study is to determine the recent characte ristics of host, pathogens, and antibiotic susceptibility of bacteria in pediatric patients with UTI living in metropo litan area of Korea for successful treatment.
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Materials and methods
A total 683 pediatric patients aged below 15 years treated for UTI from January 2012 to December 2017 were in cluded in this study. Patients were divided into five age groups (<6 months, 6-12 months, 12-24 months, 24-60, and ≥60 months). Pathogenic strains were grouped as E. coli or nonE. coli according to Gram staining, and E. coli group was subdivided into ESBL(+) and ESBL() groups depending on whether the bacteria could produce extended spectrum betalactamase (ESBL).
UTI was confirmed by body temperature greater than 38℃ using a tympanic thermometer, urine leukocytes of more than 10 per high power field view on microscopy, and colony count of pathogen at more than 10 5 colonies/mL of single organism on urine culture study. When two or more strains were cultured, the cases were excluded from this study 79) . Urine was collected in a sterilized urine bag or plastic cup after cleaning the urethral orifice area with 2% boric acid. For microscopic examination, urine samples were centri fuged and Gram stained to observe urinary bacteria and leukocytes. For culture study, 0.001 mL urine was inocul ated into blood agar medium and MacConkey agar medium separately and incubated at 37℃ for 18-24 hours. The number of bacterial colonies per 1 mL was then calculated 10) . Minimal inhibitory concentration (MIC) to the strain was determined using VITEK2 (BioMerieux), a microbial automation device according to the Clinical and Labora tory Standards Institute (CLSI). Bacteria, more than 10 5 co lonies/mL were considered to be significant as causative agents of UTI.
The antibiotic resistance of E. coli strains was analyzed. Resistance rate was expressed as {(Intermediate+Resis tance)/(Susceptible+Intermediate+Resistance)} for each susceptible, intermediate, and resistant strain to each anti biotic. Bacterial strains with moderate susceptibility in antibiotic sensitivity tests were classified as resistance.
Collected data were analyzed using SPSS 18.0 program. Differences according to gender and age groups were eva luated using Chisquare and t tests. In order to evaluate the difference in incidences among the age groups, goodness of fit was determined by Chisquare test, and crosstabulation analysis was done to establish significant differences in the incidence of UTI, by gender among the age groups. Stati stical significance was considered when P value was less than 0.05.
Results
Age and gender distribution of UTI patients
Among 683 cases, 443 (64.9%) were male and 240 (35.1 %) were female. Patients' age less than 6 months accounted for the majority (n=335, 49%), followed by 6-12 months (n=192, 28%), 12-24 months (n=53, 7.8%), 24-60 months (n=50, 7.4%) and ≥60 months (n=53, 7.8%). Thus, 77.2% of childhood UTI developed at the age under 24 months. The incidence of UTI in age <6 months group was significantly higher than others (P<0.001), and female incidence was higher only in 24-60 months age group compared to other female age groups (P<0.001, Table 1 ).
Identification of etiologic strains of UTI
Escherichia coli occurred in most cases (n=527, 77.2%), followed by Klebsiella species (n=73, 10.7%) and Entero bacter species (n=27, 4.0%). Among 24 patients who showed unusual pathogenic strains of UTI such as Staphylococcus, Enterococcus, and Streptococcus, 10 (42%) were found to have underlying disease or conditions such as De Lange syndrome, cerebral palsy, corpus callosum agenesis, cere bral infarction, ridden state, and systemic steroid use ( Table  2) .
3. Distribution of pathogens according to the age of patients Escherichia coli was the most common etiologic strain in all age groups (69.8% to 79.3%), and Klebsiella species was the second most common (4.0% to 17.0%). Citrobacter was identified 0.9-2.8% in under 24 months age groups and, Enterobacter 2.6-6.3% in under 12 months. Proteus mirabilis showed low frequency (1.0-7.7%) after 6 months of age (Table 3 ).
4.
Incidence of Escherichia coli according to age and gender of patients Incidence of Escherichia coli as the etiology of UTI was the highest (at 84.0%) in the age group of 24-60 months. It was not significantly different by gender (77.0% in males vs. 77.5% in females, P=0.876). There was no significant difference among age groups either (P=0.302) ( Table 4 )..
Incidence of ESBL(+) Escherichia coli by age and
gender of patients Among a total of 527 E. coliidentified cases, ESBLpro ducing, ESBL(+) E. coli strains were found in 126 (24%) cases, including 89 (70.6%) males and 37 (29.4%) females. Frequencies of ESBL(+) E. coli were not significantly diffe rent according to gender or age of patients (P=0.110 or P= 0.100, respectively) ( Table 5 ). There was an obvious incremental tendency in the occur rence of ESBL(+) E. coli cases by year ( Fig. 1) .
Annual incidence of ESBL(+) Escherichia coli
Over a six yearperiod from January 2012 to December 2017, the occurrence of ESBL(+) E.coli case has increased from 25.0% in 2012 to 31.9% in 2017. However, its incidence was not significantly different during these years (P=0.097, Table 6 )
Antibiotic resistance of general and ESBL(+) strains of Escherichia coli
As a result, the resistance rate of ampicillin was 71.7% and that of amoxicillin/clavulanic acid was 33.6%. Resis tance rates against third and fourth generation cephalo sporin were 23-26%. Resistance rate to ertapenem, imipe nem, and tigecycline was 0.0%. Antibiotic resistance rates of ESBL(+) E. coli to ampicillin, amoxicillin/clavulanic acid, and third/fourth generation cephalosporin were signifi cantly high; 100.0%, 49.2%, and 90.0%, respectively. Their resistance rate to ertapenem, imipenem, and tigecycline was 0.0%, which was the same as the resistance rate of all E. coli strains. Resistance rates to antibiotics other than amikacin were statistically significant between ESBL(+) and ESBL() E. coli (P<0.05, Table 7 ).
8. Incidence of ESBL(+) pathogens according to recurrence rate of UTI Among 550 patients, ESBL(+) was identified in 146 (26.5 %). Among these, 126 were E. coli and 20 were Klebsiella species. UTI recurred 220 times in 87 patients; averaging 2.52 and up to 7 times per patient. The recur rence rates of UTI seems to be related with the inci dence of ESBL(+), but there was no significant difference between the frequency www.chikd.org of ESBL(+) and relapses of UTI (P= 0.728, Table 8 ).
Incidence of VUR according to UTI recurrences
No significant statistical differences were found in the distribution of the severity of vesicoureteral reflux (VUR) between recurrent (n=87) and nonrecurrent UTI groups (n=463) (P=0.194). However, VUR was present significantly higher in recurrent group (45.9%, 34 out of 74 patients) than in nonrecurrent group (33.5%, 77 out of 230 patients) (P= 0.002, Table 9 ). In 87 recurrent UTI patients, the rate of ESBL(+) was not different by the degree of VUR (P=0.477), nor to the presence of VUR (P=0.618, Table 10 ).
Discussion
Among the 683 pediatric cases diagnosed with UTI at our institute from 2012 to 2017, 64.9% were male and 35.1% Abbreviations: VUR, vesico-ureteral reflux; ESBL, extended spectrum beta-lactamase; UTI, urinary tract infection; No data means the corresponding patients had not received VUR study. *P=0.477 is for comparison of distribution of VUR severity between ESBL (+) and ESBL(-) group.
were female. This is similar to previous studies showing a higher prevalence in male children including neonatal pe riod, and higher incidence in females after childhood, ex cept for those aged above 50 years 11) . High incidence rate of UTI in lower age groups of male might be due to poor pe nile hygiene during diaper wearing period. Current study indicated the prevalence of UTI in females was lower than that of males in early childhood, but then increased with age: from 24.2% in age <6 months, to 58.2% in age >5 years (Table 1) .
Several investigators have reported that pathogens of UTI are mainly enterobacteria, including E. coli and Enterobac teriaceae. Hooton and Stamm have reported that in the United States, E. coli, Staphylococcus, Enterococcus, and other Gramnegative organisms account for 7590%, 5-15%, and 5-10% of all UTI, respectively 12) . In the present study, the ratio of E. coli was highest at 77.2%, followed by Kleb siella at 10.7% and Enterobacter at 4.0%, showing that the portion of Gramnegative bacterial infections other than E. coli should be taken into account 13, 14) . UTI is mostly caused by ascending route through colonization and pro pagation of pathogens of lower gastrointestinal tract to perineum, urethral opening, inside urethra, then finally to the kidney 1) . Consequentially, most common causative orga nism of UTI is E. coli, while nonE. coli cases account for about 1035% 1517)
. We have a similar result of nonE. coli UTI at 23%, whilst a domestic study reported 32.9% 18) . We investigated the frequency of ESBLproducing ESBL (+) E. coli strains. UTI caused by ESBL(+) E. coli has been increasing in numbers for the last 6 years. The average pre valence rate of ESBL(+) E. coli was 24.0% in this study, which is lower than those of foreign reports, at 33-69%. However, the in cidence has increased up to 36.5% in 2017, drawing more attention for ESBL(+) E.coli infections. It was also found that 113 out of 463 patients were ESBL(+) at the time of their first visit, which led to estimate the com munity prevalence rate of ESBL(+) uropathogen to be around 24.4% in children (Table 8) .
In this study, antibiotics with resistance rates below 10% were amikacin, cefoxitin, ertapenem, imipenem, pipera cillin/tazobactam, tigecycline, and nitrofurantoin. Third and fourth generation cephalosporin such as cefepime (23.7%) and cefotaxime (26.9%) showed relatively low resis tance rates, whereas ESBL(+) E. coli showed high resistance rate to third and fourthgeneration cephalosporin such as cefepime (99.2%) and cefotaxime (99.2%). However, a con siderably low resistance rate was displayed against carba penem series antibiotics such as ertapenem (0.0%) and imi penem (0.0%). For E. coli not producing ESBL, it seems reasonable to consider third and fourthgeneration cepha losporin as the first line antibiotics. For patients with ESBL (+) E. coli cultured or serious clinical conditions, carba penem series might need to be considered initially.
Nationally, the common regime for UTI treatment is to give empirical antibiotics firstly right after diagnosis, and to discharge the patient or schedule the next visit, if there are apparent clinical improvements for a few days. After completing two weeks of antibiotics administration, the patient will come and receive tests for confirming suc cessful treatment. At times, the patient is informed late that he or she had ESBL(+) bacterial infection, even though the final followup tests are normal: no clinical sign, urine cul ture negative, and no pyuria. For such cases, we should pay close attention to prevent incomplete treatment or recur rence of UTI.
Throughout the current cases, the recurrence rate of UTI between ESBL(+) and ESBL() patients showed no signific ant difference (Table 8) , but greater in patients with vesico ureteral reflux (VUR). Severity of VUR did not affect the recurrence (Table 9 ).
In Korea, antibiotics are occasionally prescribed for treating simple pediatric febrile illnesses at primary care institutions, and this may lead to increases in antibiotic re sistance of bacteria and also to more serious renal damage, due to delayed or incomplete treatment in those misdiag nosed UTI as simple pharyngitis or acute otitis media. It was acknowledged that susceptibility of E. coli to third or fourth generation cephalosporin was higher than that to ampicillin or amoxicillin/clavulanic acid. Also, ESBL(+) E. coli showed higher resistance rate to third or fourth generation cephalosporin than ESBL() E. coli. As a result, empirical choice of antibiotics for UTI treatment may not be safe anymore due to increased frequency of ESBL(+) E. coil up to one quarter of the cases. Therefore, treatment guideline for UTI should be looked into, reflecting the re cent findings of antibiotic resistance of pathogens and host cha racteristics.
Choosing antibiotics for UTI treatment will become more difficult as the incidence of ESBL(+) E.coli is becoming more common. The success rate of primary treatment with empirical antibiotics will be lowered, and, the renal da mages will be more serious. The number of research subjects was much reduced, be cause this study included single bacterium cultured cases exclusively. In order to obtain more accurate and useful in formation for UTI treatment, additional researches should be done through extension of research period and expan sion of inclusion range of patients.
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